High-dose intravenous methotrexate with high-flux, extended-hours haemodialysis in treatment of primary central nervous system, post-transplant lymphoproliferative disorder and end-stage kidney disease: A case report

Nephrology (Carlton). 2018 Nov;23(11):1063-1064. doi: 10.1111/nep.13254.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Central Nervous System Neoplasms / etiology
  • Central Nervous System Neoplasms / therapy*
  • Humans
  • Kidney Failure, Chronic / therapy*
  • Kidney Transplantation / adverse effects*
  • Lymphoma / etiology
  • Lymphoma / therapy*
  • Male
  • Methotrexate / administration & dosage*
  • Renal Dialysis / methods*

Substances

  • Methotrexate